SEOUL, South Korea, March 19, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) in a phase 1b clinical...
Hence then, the article about gi innovation announces first clinical supply agreement to explore combination therapy for prostate cancer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer )
Also on site :
- A Dead Character's Live Text, Justin Trudeau, and a Pity Party: Inside the 'Firefly' Announcement Panel
- Lea Michele Shares Why Recording ‘Nobody’s Side’ From Broadway’s ‘Chess’ Was ‘One of The Most Incredible Moments’ Of Her Career
- Ubisoft are ending game development at long-time Tom Clancy studio Red Storm with 105 staff laid off, according to reports